Navigation Links
Updated Analysis of 2001 Epoetin Alfa Study Posted
Date:12/4/2007

BRIDGEWATER, N.J., Dec. 4 /PRNewswire/ -- An updated analysis from a 2001 study conducted by the Gynecologic Oncology Group evaluating Epoetin alfa in 109 patients with cervical cancer has been posted online (http://dx.doi.org/10.1016/j.ygyno.2007.10.011). The study (GOG-191) was terminated in 2003 due to potential concerns of thromboembolic events (TE) in the group treated with Epoetin alfa. The U.S. Food and Drug Administration (FDA) was notified at that time.

GOG-191 was a randomized phase III trial designed to evaluate the efficacy of maintaining hemoglobin levels above 12 grams per deciliter of blood (g/dL) with Epoetin alfa in subjects with advanced cervical cancer undergoing chemoradiotherapy. The updated analysis, expected to be published in the journal, Gynecologic Oncology, found a statistically non-significant trend toward decreased progression-free and overall survival in the patients treated with Epoetin alfa.

The updated analysis provides further evidence supporting the recent ESA class label change to utilize the lowest dose needed to avoid transfusions and not to exceed an upper hemoglobin safety limit of 12 g/dL.

Ortho Biotech has informed FDA of this updated analysis, and will continue to work with the agency and the GOG to ensure that these data are shared expeditiously with the medical community.

The safety and effectiveness of Epoetin alfa in its approved uses has been established in well-controlled studies and substantiated clinically over the past 20 years in more than four million patients worldwide for approved indications.

About PROCRIT (Epoetin alfa)

PROCRIT is used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on dialysis, who are being treated with zidovudine for HIV infection, and to reduce the need for t
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
2. Updated Brochure on Gynecologic Cancer Treatments Now Available
3. Medifast Announces Updated Full Year 2007 Guidance
4. Updated: National Infertility Awareness Week Nov. 4-10; Infertility Affects Significant Number of Couples
5. Long-term pharmacotherapy for obesity and overweight: updated meta-analysis
6. inVentiv Health Provides Updated Information on December 11th Investor Day
7. UPDATED: Evalve(R) Completes $60 Million Series D Financing
8. Study, meta-analysis examine factors associated with death from heatstroke
9. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 2015 On Sunday, June 14, 2015, ... – Jefferson Health will host Journey to Survivorship, a ... speaker, brunch and resources for cancer survivors and their ... the event will be Kathy LaTour, editor-at-large for Cure ... then again in 2007, LaTour provides a unique perspective ...
(Date:5/30/2015)... Chicago, Il (PRWEB) May 30, 2015 ... for Clinical Oncology (ASCO) Annual Meeting 2015 show activity ... cancer, in one case specifically against brain metastases and ... HER2+ breast cancer patients. , "I am thrilled to ... patient in her early 40s. She didn't have any ...
(Date:5/30/2015)... May 30, 2015 On Thursday, ... Dr. Charles Simone and Dr. Evan Alley both ... ‘Meet the Mesothelioma Experts’ series. The interview was ... mesothelioma centers of excellence. Drs. Simone and Alley ... Mary Hesdorffer, with whom they discussed the mesothelioma ...
(Date:5/30/2015)... 30, 2015 Nicole Blodgett, Vice ... Income Associate (DIA) designation to further her expertise ... is designed for insurance advisors, health care professionals, ... knowledge and expertise associated with the risk and ... designation is only the latest accomplishment in Nicole's ...
(Date:5/30/2015)... 2015 San Luis Obispo insurance ... offering a free analysis and consultation for anyone interested ... Disability Awareness Month, which was created by the non-profit ... United States such as Polk recognize the proclamation, and ... the possibility of disability, as well as the often-overlooked ...
Breaking Medicine News(10 mins):Health News:Abington Hospital to Host Cancer Survivorship Event 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2
... University School of Medicine will add several new pediatric clinical rotations ... , ... North Brunswick, NJ (PRWEB) February 11, 2009-- ... will add several new pediatric clinical rotations to its growing network ...
... DaVita Inc.,(NYSE: DVA ) today announced results for ... the three months ended December 31, 2008 was $98.4,million, or ... per share,for the same period of 2007. , ... Net income for the year ended December 31, ...
... today reported significantly higher sales and earnings for both its fiscal third quarter and ... , Third quarter revenue increases 16% ... , Third quarter diluted EPS increases ... quarter of fiscal 2009, net sales increased 16 percent to $5,337,000 from $4,614,000 in ...
... First-Time AttendeesSTOWE, Vt., Feb. 10 The 9th Annual ... Learning for Survivors of All Cancers, and Those Who Love ... Stowe, Vermont, opens registration on February 24th, 2009.The Stowe ... has become one of the most inspiring, educational and unprecedented ...
... 10 Allscripts-Misys Healthcare,Solutions, Inc. ("Allscripts") announced today that ... under which Allscripts may purchase up to,$150 million of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... pursuant to Rule 10b5-1 or 10b-18 of the,Securities Exchange ...
... brain, researchers say , , TUESDAY, Feb. 10 (HealthDay News) ... don,t even bother to use them because they,re difficult ... nerves are allowing the brain to communicate directly with ... a banana and fold laundry. , "In the simplest ...
Cached Medicine News:Health News:Ross University School of Medicine Expands Clinical Rotations at Miami Children's Hospital 2Health News:DaVita 4th Quarter 2008 Results 2Health News:DaVita 4th Quarter 2008 Results 3Health News:DaVita 4th Quarter 2008 Results 4Health News:DaVita 4th Quarter 2008 Results 5Health News:DaVita 4th Quarter 2008 Results 6Health News:DaVita 4th Quarter 2008 Results 7Health News:DaVita 4th Quarter 2008 Results 8Health News:DaVita 4th Quarter 2008 Results 9Health News:DaVita 4th Quarter 2008 Results 10Health News:DaVita 4th Quarter 2008 Results 11Health News:DaVita 4th Quarter 2008 Results 12Health News:DaVita 4th Quarter 2008 Results 13Health News:DaVita 4th Quarter 2008 Results 14Health News:DaVita 4th Quarter 2008 Results 15Health News:DaVita 4th Quarter 2008 Results 16Health News:DaVita 4th Quarter 2008 Results 17Health News:DaVita 4th Quarter 2008 Results 18Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:9th Annual Stowe Weekend of Hope Registration Opens February 24 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 3Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 4Health News:New Technology May Boost Artificial Arms 2
(Date:5/29/2015)... 29, 2015  Hologic, Inc. (NASDAQ: HOLX ) ... new, five-year secured credit agreement consisting of a $1.5 ... credit facility. Hologic has borrowed $0.175 billion ... and the Term Loan to pay off the Company,s ... principal amount outstanding of $1.69 billion as of March ...
(Date:5/29/2015)... 2015  Excite Medical was established by its President, ... Excite Medical, under the leadership of Mr. Musallam ... a solid track record of providing unparalleled service and ... base.  Photo - http://photos.prnewswire.com/prnh/20150529/219412 ... been possible, in large part, due to Mr. ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 Research ... of the "North America MRI Market - Growth, ... their offering. The North American MRI systems ... billion in 2014 to $1.58 billion by 2020 with ... systems are of three types namely, the open system, ...
Breaking Medicine Technology:Hologic Enters into Five-Year Secured Credit Agreement 2Hologic Enters into Five-Year Secured Credit Agreement 3North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... LLC, a global leader in,non invasive high intensity ... of the Sonablate(R) International HIFU Registry,(SIHR), along with ... Takai,Hospital Supply Co., Ltd., (THS). The SIHR is ... about prostate cancer treatment using HIFU.,It was established ...
... candidates to ... obesity patients, SAN DIEGO, July 9 Orexigen(R) Therapeutics,Inc. ... randomizing patients,in ZB-202, a second Phase IIb clinical trial for ... trial is designed,to build on highly encouraging safety and efficacy ...
Cached Medicine Technology:Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 3Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 2Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 3Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule 4
Angled 13.5 mm adjustable blades. Teeth in lower jaws fit into holes in upper jaws. Grooves in lower jaw for passage of suture needles. Round knurled handle with polished finish....
Multi-curved shafts with straight blades and longitudinal serrations. Slide lock and serrated handle with polished finish. Blade length: 27 mm....
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish....
Smooth pointed tips open to 3.0 mm. Straight shafts. Cross action. Round handle....
Medicine Products: